NANCI PARISH: Open Payments
NPI 1245348689 · PICAYUNE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 36 payments from 7 companies in 2025. Trend: 2023 $525 · 2024 $187 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $283 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $78 |
| Lilly USA, LLC | 4 | $73 |
| Astellas Pharma US Inc | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Amgen Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Veozah, UBRELVY, BREZTRI, MOUNJARO, LINZESS, QULIPTA.
Industry payments across MS — which companies pay providers there.
